--GlaxoSmithKline (GSK), which is looking to sell its consumer healthcare business in India, has drawn bids from Nestle S.A (NSRGY), Unilever N.V. (UN) and Coca-Cola Co. (KO), Reuters reported Tuesday, citing "four people familiar with the mater."

--The sale of a 72.5% stake in its GlaxoSmithKline Consumer Healthcare is expected to bring in more than $4 billion, the report said.

--An offer was not made by Reckitt Benckiser Group PLC (RBGLY), although it is looking to strengthen its consumer health operation, the report said.

--The consumer healthcare business makes such products as malt beverage Horlicks and chocolate malt drink Boost, the report said.

 

Full story: https://www.reuters.com/article/us-gsk-m-a-india-exclusive/exclusive-nestle-unilever-coke-make-bids-in-4-billion-plus-gsk-india-sale-sources-idUSKCN1LY2GT

 

--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

 

(END) Dow Jones Newswires

September 18, 2018 14:17 ET (18:17 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024 Haga Click aquí para más Gráficas Gsk.
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024 Haga Click aquí para más Gráficas Gsk.